Word

LUOXIN PHARMACEUTICAL

Status

Registered

Status Code

700

Status Date

Tuesday, October 27, 2020

Serial Number

79267215

Registration Number

6181988

Registration Date

Tuesday, October 27, 2020

Mark Type

3000

Filing Date

Thursday, July 18, 2019

Published for Opposition

Tuesday, August 11, 2020

Trademark Owner History

SHANDONG LUOXIN PHARMACEUTICAL GROUP STOCK CO., LTD. - Original Registrant

Classifications

5 Pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; pharmaceutical preparations for peripheral nervous system; medicinal tea; Chinese medicine nostrum in the nature of natural remedy preparations for the treatment of cardiovascular disease, hypertension, Alzheimer disease, depression, cancer, diabetes, lung disease, liver disease, cerebral ischemia, prostate disease, infertility, rheumatoid arthritis, immune system disease, and gastrointestinal disease; medicinal herbs; biochemical medicines for the treatment of pneumonia, urinary tract infection, gynecological infections, skin and skin structure infections, meningitis, septicemia, cancer, diabetes, prostate disease, infertility, rheumatoid arthritis, immune system disease, and gastrointestinal disease; biochemical drugs for treatment of gastrointestinal diseases; antiseptics; dental lacquer; diapers for pets; medicinal alcohol; medicinal oils; amino acids for medical purposes

Color is not claimed as a feature of the mark.
THE NON-LATIN CHARACTERS THAT TRANSLITERATE TO "YAO YE" AND THE WORD "PHARMACEUTICAL"
The mark consists of a design comprising two intersecting curved bands with horizontal stripes that form a Y-shaped figure. Above this design is an eight-pointed star. Two non-Latin characters appear, respectively, on the left and right of the bottom of the design. To the right of the foregoing elements are four non-Latin characters in horizontal arrangement above the wording "LUOXIN PHARMACEUTICAL" in stylized lettering.
LUO XIN PHARMACEUTICAL
The transliteration of the non-Latin characters in the mark is: The two non-Latin characters on the left of the mark from left to right transliterate to "LUO""XIN", where "LUO" is a surname and "XIN" means "GLAD" in English. The four non-Latin characters on the right of the mark from left to right transliterate to "LUO" "XIN" "YAO" "YE" where "LUO" is a surname, "XIN" means "GLAD" and "YAO YE" means "PHARMACEUTICAL" in English.
The English translation of the word "LUOXIN" in the mark is comprised of the surname "LUO" and the term "XIN", which means "GLAD" in English.

Trademark Events

Mar 7, 2021

Final Decision Transaction Processed By Ib

Feb 9, 2021

Generic Madrid Transaction Sent To Ib

Feb 9, 2021

Generic Madrid Transaction Created

Jan 27, 2021

Final Disposition Notice Created, To Be Sent To Ib

Oct 27, 2020

Registered-Principal Register

Aug 11, 2020

Official Gazette Publication Confirmation E-Mailed

Aug 11, 2020

Published For Opposition

Aug 7, 2020

Notification Processed By Ib

Jul 22, 2020

Notification Of Possible Opposition Sent To Ib

Jul 22, 2020

Notice Of Start Of Opposition Period Created, To Be Sent To Ib

Jul 22, 2020

Notification Of Notice Of Publication E-Mailed

Jul 8, 2020

Approved For Pub - Principal Register

Jul 8, 2020

Examiner's Amendment Entered

Jul 8, 2020

Notification Of Examiners Amendment E-Mailed

Jul 8, 2020

Examiners Amendment E-Mailed

Jul 8, 2020

Examiners Amendment -Written

Jun 16, 2020

Teas/Email Correspondence Entered

Jun 16, 2020

Correspondence Received In Law Office

Jun 8, 2020

Teas Response To Office Action Received

Mar 27, 2020

Refusal Processed By Ib

Feb 20, 2020

Notification Of Non-Final Action E-Mailed

Feb 20, 2020

Non-Final Action E-Mailed

Feb 20, 2020

Non-Final Action Written

Jan 22, 2020

Assigned To Examiner

Dec 26, 2019

Teas/Email Correspondence Entered

Dec 26, 2019

Correspondence Received In Law Office

Dec 23, 2019

Assigned To Lie

Dec 14, 2019

Refusal Processed By Ib

Dec 8, 2019

Teas Response To Office Action Received

Nov 27, 2019

Non-Final Action Mailed - Refusal Sent To Ib

Nov 27, 2019

Refusal Processed By Mpu

Nov 5, 2019

Non-Final Action (Ib Refusal) Prepared For Review

Nov 4, 2019

Non-Final Action Written

Oct 4, 2019

Assigned To Examiner

Sep 24, 2019

Application Filing Receipt Mailed

Sep 18, 2019

New Application Office Supplied Data Entered In Tram

Sep 17, 2019

Limitation From Original Application Entered

Sep 12, 2019

Sn Assigned For Sect 66a Appl From Ib